BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 30753907)

  • 21. β-Lactamase-non-producing ampicillin-resistant Haemophilus influenzae is acquiring multidrug resistance.
    Yamada S; Seyama S; Wajima T; Yuzawa Y; Saito M; Tanaka E; Noguchi N
    J Infect Public Health; 2020 Apr; 13(4):497-501. PubMed ID: 31839585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms, molecular and sero-epidemiology of antimicrobial resistance in bacterial respiratory pathogens isolated from Japanese children.
    Sunakawa K; Farrell DJ
    Ann Clin Microbiol Antimicrob; 2007 Aug; 6():7. PubMed ID: 17697316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of in vitro antimicrobial activity of AM-1155 with those of tosufloxacin and fleroxacin against clinical isolates of Neisseria gonorrhoeae harboring quinolone resistance alterations in GyrA and ParC.
    Deguchi T; Yasuda M; Nakano M; Ozeki S; Kanematsu E; Fukuda H; Maeda S; Saito I; Kawada Y
    Chemotherapy; 1997; 43(4):239-44. PubMed ID: 9209780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emergence of clonally related multidrug resistant Haemophilus influenzae with penicillin-binding protein 3-mediated resistance to extended-spectrum cephalosporins, Norway, 2006 to 2013.
    Skaare D; Anthonisen IL; Kahlmeter G; Matuschek E; Natås OB; Steinbakk M; Sundsfjord A; Kristiansen BE
    Euro Surveill; 2014 Dec; 19(49):. PubMed ID: 25523969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serotypes, antimicrobial susceptibility, and beta-lactam resistance mechanisms of clinical Haemophilus influenzae isolates from Bulgaria in a pre-vaccination period.
    Setchanova LP; Kostyanev T; Markovska R; Miloshev G; Mitov IG
    Scand J Infect Dis; 2013 Feb; 45(2):81-7. PubMed ID: 22992181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutant selection window of four quinolone antibiotics against clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis.
    Nakai H; Sato T; Uno T; Furukawa E; Kawamura M; Takahashi H; Watanabe A; Fujimura S
    J Infect Chemother; 2018 Feb; 24(2):83-87. PubMed ID: 29290527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro activity of tosufloxacin (A-60969) and clarithromycin (A-56268, TE-031) against resistant Haemophilus influenzae, Streptococcus pneumoniae and Branhamella catarrhalis isolates.
    Bryan JP; Waters C; Sheffield J; Wagner KF
    Eur J Clin Microbiol Infect Dis; 1990 May; 9(5):361-5. PubMed ID: 2142647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro antibacterial activities of new fluoroquinolones against clinical isolates of haemophilus influenzae with ciprofloxacin-resistance-associated alterations in GyrA and ParC.
    Yoshizumi S; Takahashi Y; Watanabe Y; Okezaki E; Ishii Y; Tateda K
    Chemotherapy; 2004 Dec; 50(6):265-75. PubMed ID: 15608441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutant ftsI genes in the emergence of penicillin-binding protein-mediated beta-lactam resistance in Haemophilus influenzae in Norway.
    Skaare D; Allum AG; Anthonisen IL; Jenkins A; Lia A; Strand L; Tveten Y; Kristiansen BE
    Clin Microbiol Infect; 2010 Aug; 16(8):1117-24. PubMed ID: 19737286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular characterisation of the clonal emergence of high-level ciprofloxacin-monoresistant Haemophilus influenzae in the Region of Southern Denmark.
    Fuursted K; Hartmeyer GN; Stegger M; Andersen PS; Justesen US
    J Glob Antimicrob Resist; 2016 Jun; 5():67-70. PubMed ID: 27436470
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multilocus sequence typing and ftsI sequencing: a powerful tool for surveillance of penicillin-binding protein 3-mediated beta-lactam resistance in nontypeable Haemophilus influenzae.
    Skaare D; Anthonisen IL; Caugant DA; Jenkins A; Steinbakk M; Strand L; Sundsfjord A; Tveten Y; Kristiansen BE
    BMC Microbiol; 2014 May; 14():131. PubMed ID: 24884375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nationwide survey of the development of drug resistance in the pediatric field in 2000-2001, 2004, 2007, 2010, and 2012: evaluation of the changes in drug sensitivity of Haemophilus influenzae and patients' background factors.
    Shiro H; Sato Y; Toyonaga Y; Hanaki H; Sunakawa K
    J Infect Chemother; 2015 Apr; 21(4):247-56. PubMed ID: 25596977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High diversity of invasive Haemophilus influenzae isolates in France and the emergence of resistance to third generation cephalosporins by alteration of ftsI gene.
    Deghmane AE; Hong E; Chehboub S; Terrade A; Falguières M; Sort M; Harrison O; Jolley KA; Taha MK
    J Infect; 2019 Jul; 79(1):7-14. PubMed ID: 31100360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of Haemophilus species in patients with respiratory tract infections in Yaoundé, Cameroon.
    Tchatchouang S; Nzouankeu A; Hong E; Terrade A; Denizon M; Deghmane AE; Ndiang SMT; Pefura-Yone EW; Penlap Beng V; Njouom R; Fonkoua MC; Taha MK
    Int J Infect Dis; 2020 Nov; 100():12-20. PubMed ID: 32827751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Surveillance of antimicrobial susceptibility of Haemophilus influenzae isolates from children in Beijing, Shanghai, and Guangzhou 2000 - 2002].
    Shen XZ; Lu Q; Deng L; Yu SJ; Zhang H; Deng QL; Jiang M; Hu YY; Yang YH
    Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(16):1335-9. PubMed ID: 15387940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of β-lactamase-negative ampicillin-resistant haemophilus influenzae isolated from patients of a teaching hospital in Thailand.
    Lulitanond A; Chanawong A; Pienthaweechai K; Sribenjalux P; Tavichakorntrakool R; Wilailuckana C; Puang-Ngern P; Saetung P
    Jpn J Infect Dis; 2012; 65(2):122-5. PubMed ID: 22446118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular characterization of fluoroquinolones, macrolides, and imipenem resistance in Haemophilus influenzae: analysis of the mutations in QRDRs and assessment of the extent of the AcrAB-TolC-mediated resistance.
    Cherkaoui A; Gaïa N; Baud D; Leo S; Fischer A; Ruppe E; François P; Schrenzel J
    Eur J Clin Microbiol Infect Dis; 2018 Nov; 37(11):2201-2210. PubMed ID: 30145620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The PROTEKT surveillance study: antimicrobial susceptibility of Haemophilus influenzae and Moraxella catarrhalis from community-acquired respiratory tract infections.
    Hoban D; Felmingham D
    J Antimicrob Chemother; 2002 Sep; 50 Suppl S1():49-59. PubMed ID: 12239228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alternative quinolone-resistance pathway caused by simultaneous horizontal gene transfer in Haemophilus influenzae.
    Tanaka E; Wajima T; Nakaminami H; Uchiya KI
    J Antimicrob Chemother; 2022 Nov; 77(12):3270-3274. PubMed ID: 36124853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Imipenem heteroresistance in nontypeable Haemophilus influenzae is linked to a combination of altered PBP3, slow drug influx and direct efflux regulation.
    Cherkaoui A; Diene SM; Renzoni A; Emonet S; Renzi G; François P; Schrenzel J
    Clin Microbiol Infect; 2017 Feb; 23(2):118.e9-118.e19. PubMed ID: 27756711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.